Context-dependent tonic signaling shapes the performance and manufacturability of a 4-1BB- based HER2 CAR-T cell therapy
Laura Angelats, Berta Marzal, Alba Rodríguez-García, Marta Español‐Rego, Teresa Lobo‐Jarne, María Hernández‐Sánchez, Guim Cascalló, Salut Colell, Marta Giménez-Alejandre, Guillem Colell, Joan Castellsagué, Irene Andreu-Saumell, Hugo Calderón, Patricia Galván, Álvaro Urbano-Ispizúa, , Sònia Guedan
This study shows that tonic signaling in 4-1BB-based HER2 CAR-T cells affects manufacturability and performance, with context-dependent outcomes based on manufacturing conditions.
bioRxiv · May 14, 2026 · PreprintImmunology